FDA launches new drug safety newsletter
Patient Safety Monitor Alert, September 26, 2007
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
The Food and Drug Administration (FDA) issued a new drug safety newsletter last week that describes potential risks of several medicines, according to a Reuters article.
The Drug Safety Newsletter is aimed at healthcare professionals and details side effects associated with the cancer drug Rituxan, narcolepsy drug Provigil, brain cancer medication Temodar, and blood infusion drug Exjade. The report makes good on a commitment made by the FDA after the Institute of Medicine issued a report in 2006 criticizing the agency's record of policing drugs once they were on the market.
The newsletter will be published quarterly. Visit http://www.fda.gov/cder/dsn/ to read the first issue.
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Related Products
-
Patient Safety Monitor
As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...
-
Patient Safety Monitor Alert
This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...
-
Patient Safety Quality Monthly
Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...
-
Occurrence Reporting:
Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q&A: Coding for dry skin due to cold weather
- Q/A: Volume requirement for reporting hydration services
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Privacy, security concerns high in HIEs
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- HIPAA Q&A: TPO disclosures to a business associate
- Are your workforce members texting PHI?
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- Hospitalist-surgeon comanagement has no effect on outcomes
- Don't let these sentinel events trigger falsely
- Searched